Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dropless Pars Plana Vitrectomy Study
Sponsor: Massachusetts Eye and Ear Infirmary
Summary
To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
168
Start Date
2022-07-25
Completion Date
2027-01-30
Last Updated
2025-06-25
Healthy Volunteers
Yes
Conditions
Interventions
Pars plana vitrectomy
Standard of care surgery
Triamcinolone Acetonide 40mg/mL
Sub-tenon injection of triamcinolone acetonide (40mg/mL) at the time of surgery
Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin
Antibiotic eye drop 4 times per day for 1 week after surgery
Prednisolone 1%
Steroid eye drop 4 times per day tapered by one drop weekly for 4 weeks (4/3/2/1 taper) after surgery
Atropine 1%
Eye drop daily for 1 week after surgery
Locations (1)
Massachusetts Eye and Ear
Boston, Massachusetts, United States